RTRB-17 NEURAL PROGENITOR CELL (NPC) SPARING RADIATION THERAPY PLUS TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) ASSOCIATED WITH COGNITIVE FUNCTION BUT NOT TUMOR OUTCOMES: RESULTS OF A SINGLE ARM PROSPECTIVE CLINICAL TRIAL

Documenti analoghi

• A Prospective Cohort Study of Neural Progenitor Cell-Sparing Radiation Therapy Plus Temozolomide for Newly Diagnosed Patients With Glioblastoma
  di: Gui, Chengcheng, et al.
  Pubblicazione: (2020)
• RTRB-15 CONCURRENT TEMOZOLOMIDE AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT HIGH GRADE GLIOMA
  di: Palmer, Joshua, et al.
  Pubblicazione: (2015)
• RTRB-21 SURVIVAL ANALYSIS OF 161 ELDERLY PATIENTS TREATED WITH RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE
  di: Torcuator, Roy, et al.
  Pubblicazione: (2015)
• RTRB-22 HYPOFRACTIONATED RADIOTHERAPY VERSUS STANDARD FRACTIONATED RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
  di: Wang, Tony, et al.
  Pubblicazione: (2015)
• RTRB-24 SYMBIOSIS BETWEEN GBM CELL SUBPOPULATIONS, WITH OR WITHOUT EGFR AMPLIFICATION, IS A NEW MECHANISM OF TUMOR RESISTANCE TO RADIATION THERAPY
  di: Zhou, Yi-Hong, et al.
  Pubblicazione: (2015)